Dianthus Therapeutics, Inc. — Form D
Dianthus Therapeutics, Inc. of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-06-07. The offering totals $15.0M, of which $15.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-06-07
- Form: D
- Accession: 0001783732-21-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $15.0M
- Remaining: $4
- Investors: 6
- Date of first sale: 2021-05-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-401968
Issuer
- Name: Dianthus Therapeutics, Inc.
- CIK: 0001783732
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 203 CRESCENT STREET, BLDG #4, STE 205, WALTHAM, MA, 02453
- Phone: 917-607-3065
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Jonathan Violin | Director | Waltham, MA |
| Jonathan Violin | Executive Officer | Waltham, MA |
| Leon O Moulder, Jr. | Director | Exton, PA |
| Tomas Evan Kiselak | Director | Waltham, MA |
| Kenneth Evan Thompson | Executive Officer | Waltham, MA |
| Paula Evan Soteropoulos | Director | Peabody, MA |
| Jonathan Evan Violin | Director | Waltham, MA |
| Lei Evan Meng | Director | Greenwich, CT |
| Marino Garcia | Director | Waltham, MA |
| Marino Garcia | Executive Officer | Waltham, MA |
| Leon Moulder | Director | Woburn, MA |
| Leon Evan Moulder | Director | Waltham, MA |
| Leon Moulder, Jr. | Director | Waltham, MA |
Other filings by this issuer (4)
More